Syringes containing 24g of an 18.75% paste formulation of fenbendazole and 0.2% apple and cinnamon flavour as a ready to administer oral anthelmintic for horses. 1g Panacur Equine Paste contains 0.187g active ingredient Fenbendazole PhEur.

A broad spectrum anthelmintic for the treatment and control of adult and immature roundworms of the gastro-intestinal tract in horses and other equines. Panacur also has an ovicidal effect on nematode eggs.

Panacur effectively treats and controls the following roundworm infections:

Large strongyles (adults and migrating larval stages of S. vulgaris; adults and tissue larval stages of S. edentatus).
Benzimidazole susceptible adult and immature small strongyles (Cyathostomes) including encysted mucosal 3rd and 4th stage larvae; it is also effective against encysted inhibited 3rd stage larvae in the mucosa.
Adult and immature Oxyuris spp., Strongyloides spp., and Parascaris equorum.

No dietary control is required before or after treatment.

Routine treatment

Administer orally, 1 syringe per 600 kg bodyweight (= 7.5 mg fenbendazole/kg bodyweight).

Practical dosage recommendations

Increased dosing for specific infections:
Five day course

For the treatment and control of migrating and tissue larval stages of large strongyles, encysted mucosal 3rd and 4th stage small strongyle larvae and encysted inhibited 3rd stage small strongyle larvae in the mucosa, administer 1 syringe per 600kg bodyweight daily for 5 days (=7.5mg fenbendazole/kg bodyweight daily for 5 days).

Single dose treatments

For the treatment and control of encysted mucosal stages of small strongyles administer 1 syringe per 150kg bodyweight (=30 mg fenbendazole/kg bodyweight).
For the treatment and control of migrating larval and tissue stages of large strongyles administer 1 syringe per 75kg bodyweight (=60 mg fenbendazole/kg bodyweight).
For the treatment and control of Strongyloides westeri in suckling foals administer 1 syringe per 90kg bodyweight (=50 mg fenbendazole/kg bodyweight).
Panacur Equine Paste should be administered orally by squeezing the paste from the syringe onto the back of the horse's tongue.
Assess bodyweight as accurately as possible before calculating the dosage. The use of a `weigh-band' is recommended.
Pregnant mares and young foals can be safely treated with Panacur Equine Paste (fenbendazole) at recommended dosage levels.

Recommended dosing programmes

All horses should be routinely treated with the single dose of Panacur Equine Paste every 6–8 weeks.
Treatment of encysted inhibited and encysted mucosal dwelling larvae should ideally be performed in the autumn (ideally late October/November) and again in the spring (ideally in February). However, for horses that fail to maintain condition or bought-in horses with unknown worming history, the treatment should be given at any time of year.

Do not use in horses intended for human consumption.

Operator warnings

Direct contact with the skin should be kept to a minimum. Wear impermeable rubber gloves while administering the product. Wash hands after use.

Environmental warnings

Dispose of any unused product and empty syringes in accordance with guidance from your local waste regulation authority.

For animal treatment only. Keep out of reach of children.

Do not store above 25°C. Protect from direct sunlight.

24 g syringes and packs of 20×24 g syringes.

Studies have indicated that inhibited 3rd stage small strongyle larvae represent 50% of the total larval population in the horse.

Panacur has been used extensively for the treatment of worm infestations in exotic animal species. For further information on suggested dose rates, please contact the Veterinary Adviser of the company.